Related Experiment Video
Updated: Sep 6, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice
Christine M Sorenson1, Nader Sheibani
1Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin 53792, USA. cmsorenson@facstaff.wisc.edu
Abstract:
Cell proliferation, survival, and differentiation are carefully orchestrated processes during nephrogenesis that become aberrant during renal cyst formation. Signaling through focal adhesion kinase (FAK) impacts these processes, although its role during nephrogenesis requires further delineation. We previously demonstrated that phosphorylation of FAK and paxillin is not downregulated in cystic kidneys from B cell lymphoma/leukemia-2 (bcl-2) -/- mice. Here we examine whether FAK downstream signaling pathways are affected in these cystic kidneys. Cystic kidneys from bcl-2 -/- mice exhibited sustained phosphorylation of Src and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK, ERK1). However, similar levels of expression were noted for phosphorylated c-Jun NH(2)-terminal kinase, phosphatidylinositol-3-kinase, and its target protein kinase B/ATP-dependent tyrosine kinase in kidneys from postnatal day 20 bcl-2 +/+ and bcl-2 -/- mice. We also examined expression of the adapter protein Shc, implicated in growth and apoptosis. Expression of p66(Shc) decreases to low levels in postnatal kidneys, whereas p52/p46(Shc) was constitutively expressed during nephrogenesis. Shc expression was similar in normal and cystic kidneys. Therefore, sustained activation of MAPK/ERKs through the Src/FAK pathway may contribute to the hyperproliferation observed in cystic kidneys from bcl-2 -/- mice.
Insights
Aberrant kidney development involves focal adhesion kinase (FAK) signaling. In B cell lymphoma/leukemia-2 (bcl-2) knockout mice, sustained MAPK/ERK activation via Src/FAK contributes to renal cyst hyperproliferation.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Signaling
Background:
- Nephrogenesis involves regulated cell proliferation, survival, and differentiation.
- Aberrant signaling pathways, including focal adhesion kinase (FAK), are implicated in renal cyst formation.
- Previous studies showed sustained FAK and paxillin phosphorylation in cystic kidneys of B cell lymphoma/leukemia-2 (bcl-2) knockout mice.
Purpose of the Study:
- To investigate the downstream signaling pathways affected by FAK in the context of cystic kidneys.
- To determine the role of FAK-mediated signaling in the hyperproliferation observed in bcl-2 knockout mouse kidneys.
Main Methods:
- Analysis of protein phosphorylation and expression levels in kidney tissues from postnatal day 20 bcl-2 +/+ and bcl-2 -/- mice.
- Western blotting was used to assess the activation status of key signaling molecules, including Src, MAPK/ERK, c-Jun NH2-terminal kinase, phosphatidylinositol-3-kinase, protein kinase B, and Shc proteins.
Main Results:
- Cystic kidneys from bcl-2 -/- mice exhibited sustained phosphorylation of Src and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK).
- Phosphorylation levels of c-Jun NH2-terminal kinase, phosphatidylinositol-3-kinase, and protein kinase B were similar in normal and cystic kidneys.
- Expression of Shc adapter proteins (p66Shc, p52/p46Shc) was comparable between normal and cystic kidneys, with p52/p46Shc constitutively expressed during nephrogenesis.
Conclusions:
- Sustained activation of the MAPK/ERK pathway, potentially through the Src/FAK signaling cascade, may drive the observed hyperproliferation in cystic kidneys of bcl-2 -/- mice.
- These findings highlight the critical role of FAK-mediated signaling in regulating cell proliferation during kidney development and disease.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

